Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 10135
Country/Region: Mozambique
Year: 2015
Main Partner: Abt Associates
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 42,682
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 239,687
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 130,142
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 21,566
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 28,758
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 325
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 325
GEND_GBV Number of people receiving post-GBV care 2016 3,983
HRH_PRE By Graduates: Nurses 2016 82
HRH_PRE By Graduates: Other 2016 82
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2016 164
HRH_PRE Sum of Graduates disaggregates 2016 194
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 142,752
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 666,996
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 1,044
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 15,473
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 2,603
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 15,473
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 1,044
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 6,190
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 1,559
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 9,283
PMTCT_ARV Sum of New and Current disaggregates 2016 2,603
PMTCT_ARV Sum of New and Current disaggregates 2016 15,473
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 11,833
PMTCT_STAT By: Known positives at entry 2016 301
PMTCT_STAT By: Known positives at entry 2016 4,486
PMTCT_STAT By: Number of new positives identified 2016 743
PMTCT_STAT By: Number of new positives identified 2016 10,987
PMTCT_STAT Number of new ANC and L&D clients 2016 60,102
PMTCT_STAT Number of new ANC and L&D clients 2016 166,060
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 60,078
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 174,360
PMTCT_STAT Sum of Positives Status disaggregates 2016 1,044
PMTCT_STAT Sum of Positives Status disaggregates 2016 15,473
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 8,313
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 7,481
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 42,682
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 239,687
TX_CURR Age/Sex: <1 Female 2016 325
TX_CURR Age/Sex: <1 Female 2016 1,417
TX_CURR Age/Sex: <1 Male 2016 325
TX_CURR Age/Sex: <1 Male 2016 1,417
TX_CURR Age/Sex: 1-4 Female 2016 739
TX_CURR Age/Sex: 1-4 Female 2016 3,210
TX_CURR Age/Sex: 1-4 Male 2016 739
TX_CURR Age/Sex: 1-4 Male 2016 3,210
TX_CURR Age/Sex: 5-14 Female 2016 523
TX_CURR Age/Sex: 5-14 Female 2016 2,269
TX_CURR Age/Sex: 5-14 Male 2016 523
TX_CURR Age/Sex: 5-14 Male 2016 2,269
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 29,877
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 167,783
TX_CURR Sum of age/sex disaggregates 2016 13,792
TX_CURR Sum of Age/Sex disaggregations 2016 3,174
TX_NEW Aggregated Grouping by Age: <1 Male 2016 531
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 531
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 33,100
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 17,828
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 56,129
TX_NEW Pregnancy status 2016 9,283
TX_NEW Sum of Age/Sex disaggregates 2016 2,422
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 50,928
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 31,379
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 41,125
VMMC_CIRC By Age: 10-14 2016 12,403
VMMC_CIRC By Age: 15-19 2016 12,403
VMMC_CIRC By Age: 20-24 2016 10,334
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 41,342
VMMC_CIRC Sum of age disaggregates 2016 35,140